Indicative Announcement on "Shouxiangu 22 Convertible Bonds" Expected to Meet the Conditions for Revising the Conversion Price Downward
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603896)"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Indicative Announcement on "Shouxiangu 22 Convertible Bonds" Expected to Meet the Conditions for Revising the Conversion Price Downward
Filed with SSE · Stock code 603896 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Story so far
- Announcement on Not Revising Downward the Conversion Price of "Shouxiangu 22 Convertible Bonds"
- Indicative Announcement on "Shouxiangu 22 Convertible Bonds" Expected to Meet Conditions for Revising Downward Conversion Price
- Indicative Announcement on "Shouxiangu 22 Convertible Bond" Expected to Meet Conditions for Revising Conversion Price Downward
Earlier from Zhejiang Shouxiangu Pharmaceutical
- (603896)"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Release of Certain Guarantees for Wholly-owned Subsidiary
- (603896)"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- (603896)"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Conversion Results of "Shouxiangu 22 Convertible Bonds" and Share Changes
- Announcement on the 2026 Shareholder Rewards Event for the Mid-Autumn Festival
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical